Millennium Selling Notes

It wants to raise $200 million.
Author:
Publish date:

Drugs manufacturer

Millennium Pharmaceuticals

(MLNM)

filed a registration statement with the SEC indicating its intention to offer $200 million of convertible senior notes due Nov. 15, 2011.

The Cambridge, Mass.-based company expects to use the proceeds mainly for license arrangements and acquisitions.

This story was created through a joint venture between TheStreet.com and IRIS.